Why does the quality of TURBT matter more than ever in the era of novel bladder cancer therapies?
In this EMUC TV interview, our UROONCO BCa associate editor Dr. Roberto Contieri speaks with Prof. Jonathan Aning about the critical role of high-quality transurethral resection of bladder tumours (TURBT) in diagnosis, staging, and long-term patient outcomes.